Open access
Open access
Powered by Google Translator Translator

Supplement: The future of JAK1 selective inhibitors in rheumatology.

26 Aug, 2021 | 08:30h | UTC

Homepage: The future of JAK1 selective inhibitors – Rheumatology

How important is JAK1 selectivity?

JAK1: Number one in the family; number one in inflammation?

Early phase studies of JAK1 selective inhibitors in rheumatoid arthritis

Phase III trials of JAK1 selective inhibitors in rheumatoid arthritis

The safety of JAK-1 inhibitors

Clinical use of Jak 1 inhibitors for rheumatoid arthritis

JAK1 selective inhibitors for the treatment of spondyloarthropathies

JAK1 inhibition and inflammatory bowel disease

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.